Quality-adjusted life years among people who inject drugs in a needle syringe program in Sweden.

Martin Kåberg, Sofie Larsson, Jakob Bergström, Anders Hammarberg
Author Information
  1. Martin Kåberg: Department of Global Public Health, Karolinska Institutet, 171 77, Stockholm, Sweden. martin.kaberg@ki.se. ORCID
  2. Sofie Larsson: Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Stockholm, Sweden. ORCID
  3. Jakob Bergström: Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Stockholm, Sweden.
  4. Anders Hammarberg: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. ORCID

Abstract

PURPOSE: Needle syringe programs (NSP) significantly reduce risk behavior and HIV and hepatitis transmission in people who inject drugs (PWID). However, PWID are underrepresented in studies on health-related quality of life (HRQoL), representing a barrier to evaluate effects of public health and preventive measures related to injecting drug use. In this study, we investigate how well the two questionnaires EQ-5D-3L and SF-6D measure health in PWID. We also estimate HRQoL in the PWID population.
METHOD: Data on demographics, injection drug use, HIV, hepatitis status, and self-reported HRQoL were collected from 550 PWID enrolled in the Stockholm NSP at enrollment and at 6-, 12-, and 24-month follow-up. Self-rated HRQoL was measured as QALY, using EQ-5D-3L and the SF-6D. Item response theory (IRT) was used to evaluate which of the two instruments that measure health most accurately in this population. Regression analysis was used to estimate population-specific QALYs.
RESULTS: The IRT analysis showed that SF-6D was better suited to measure health in PWID. More specifically, SF-6D to a larger extent discriminated between persons regardless of their health status, while EQ-5D was more suitable to detect persons with poorer health. Self-rated HRQoL showed that average QALY was lower among PWID compared to the general Swedish population. However, a general increase in self-reported health was noted over time among participants.
CONCLUSION: This study increase knowledge of what instruments are most suitable to measure health among PWID. This is of great importance when evaluating effects of public health and preventive measures in the PWID population.

Keywords

References

  1. Med Care. 1996 Mar;34(3):220-33 [PMID: 8628042]
  2. Qual Life Res. 2005 Aug;14(6):1523-32 [PMID: 16110932]
  3. Lancet Infect Dis. 2016 Dec;16(12):1385-1398 [PMID: 27665254]
  4. Harm Reduct J. 2020 Oct 22;17(1):84 [PMID: 33092595]
  5. Int J Drug Policy. 2016 Apr;30:74-81 [PMID: 27017376]
  6. Soc Sci Med. 1995 Nov;41(10):1403-9 [PMID: 8560308]
  7. J Hepatol. 2016 Jul;65(1):17-25 [PMID: 26867489]
  8. Philos Trans A Math Phys Eng Sci. 2016 Apr 13;374(2065):20150202 [PMID: 26953178]
  9. Shanghai Arch Psychiatry. 2014 Jun;26(3):171-7 [PMID: 25114494]
  10. Lancet Psychiatry. 2018 Dec;5(12):987-1012 [PMID: 30392731]
  11. Int J Drug Policy. 2013 Jul;24(4):342-50 [PMID: 23127664]
  12. Infect Dis (Lond). 2017 Oct;49(10):728-736 [PMID: 28574295]
  13. Int J Drug Policy. 2019 Apr;66:87-93 [PMID: 30743093]
  14. Qual Life Res. 2013 Oct;22(8):2113-21 [PMID: 23341173]
  15. Can Commun Dis Rep. 2004 Jul 15;30(14):125-32 [PMID: 15279499]
  16. J Hepatol. 2013 Mar;58(3):460-6 [PMID: 23149064]
  17. Addiction. 2018 Mar;113(3):545-563 [PMID: 28891267]
  18. Am J Public Health. 2000 Jul;90(7):1100-11 [PMID: 10897189]
  19. Biomed Res Int. 2018 Oct 4;2018:8346195 [PMID: 30402495]
  20. PLoS One. 2017 May 31;12(5):e0178474 [PMID: 28562646]
  21. J Ment Health Policy Econ. 2009 Mar;12(1):27-31 [PMID: 19346564]
  22. Infect Dis (Lond). 2020 May;52(5):336-346 [PMID: 32072841]
  23. Int J Drug Policy. 2021 Apr;90:103059 [PMID: 33360734]
  24. Curr Opin Psychiatry. 2012 May;25(3):213-8 [PMID: 22449767]
  25. Eur J Health Econ. 2009 Feb;10(1):15-23 [PMID: 18327677]
  26. Health Qual Life Outcomes. 2013 May 09;11:81 [PMID: 23659557]
  27. Lancet Glob Health. 2017 Dec;5(12):e1208-e1220 [PMID: 29074410]
  28. J Clin Epidemiol. 1998 Nov;51(11):1171-8 [PMID: 9817135]
  29. Med Care. 2004 Sep;42(9):851-9 [PMID: 15319610]
  30. Health Policy. 1990 Dec;16(3):199-208 [PMID: 10109801]
  31. AIDS. 2006 Nov 14;20(17):2207-15 [PMID: 17086061]
  32. Int J Drug Policy. 2014 Jan;25(1):34-52 [PMID: 23973009]
  33. J Viral Hepat. 2017 Feb;24(2):117-127 [PMID: 27790803]
  34. Subst Abuse Treat Prev Policy. 2019 Jan 3;14(1):2 [PMID: 30606188]
  35. Med Care. 1997 Nov;35(11):1095-108 [PMID: 9366889]
  36. J Viral Hepat. 2018 Dec;25(12):1452-1461 [PMID: 29998522]
  37. PLoS One. 2014 Aug 11;9(8):e104515 [PMID: 25110927]
  38. Health Policy. 2006 May;76(3):359-70 [PMID: 16214258]

MeSH Term

Humans
Quality of Life
Sweden
Quality-Adjusted Life Years
Substance Abuse, Intravenous
Drug Users
Syringes
Surveys and Questionnaires
Self Report
HIV Infections

Word Cloud

Created with Highcharts 10.0.0PWIDhealthHRQoLSF-6DmeasurepopulationamongsyringeinjectdrugsQALYNeedleNSPHIVhepatitispeopleHoweverlifeevaluateeffectspublicpreventivemeasuresdrugusestudytwoEQ-5D-3Lestimatestatusself-reportedSelf-ratedIRTusedinstrumentsanalysisshowedpersonsEQ-5DsuitablegeneralincreaseprogramPURPOSE:programssignificantlyreduceriskbehaviortransmissionunderrepresentedstudieshealth-relatedqualityrepresentingbarrierrelatedinjectinginvestigatewellquestionnairesalsoMETHOD:Datademographicsinjectioncollected550enrolledStockholmenrollment6-12-24-monthfollow-upmeasuredusingItemresponsetheoryaccuratelyRegressionpopulation-specificQALYsRESULTS:bettersuitedspecificallylargerextentdiscriminatedregardlessdetectpooreraveragelowercomparedSwedishnotedtimeparticipantsCONCLUSION:knowledgegreatimportanceevaluatingQuality-adjustedyearsneedleSwedenHarmreductionPeople

Similar Articles

Cited By